Navigation Links
CHI Vice President Provides Testimony On Patient, Physician Notification of Biosimilar Substitution
Date:4/8/2013

La Jolla, CA (PRWEB) April 08, 2013

California Healthcare Institute (CHI) Vice President of State Government Affairs Eve Bukowski today provided testimony before the Senate Business, Professions and Economic Development Committee on the importance of notifying physicians when a patient’s biologic prescription has been substituted with a biosimilar drug.

Bukowski, who was diagnosed with stage-four colon cancer, spoke from personal experience and urged the committee to consider patients in the process.

“All of us with diseases treated with biologic medicines understand the instability of our health and the risks of side effects associated with our treatments. It’s a risk we are willing to take for the benefits we receive,” Bukowski said. “Informing the physician of a substitution is not only consistent with current pharmacist-physician interaction, it’s a simple precautionary step.”

Unlike their pharmaceutical counterparts, biotech drugs are made from living organisms and derive from more complex manufacturing processes involving sensitive fermentation and purification. Biosimilars are products “highly similar to” or “interchangeable” with a U.S. Food and Drug Administration-licensed biological product.

New legislation known as SB 598 and authored by Sen. Jerry Hill (D-San Mateo) would regulate the dispensing of biosimilars. It would require patient and physician notification of biosimilar substitution and that the full name and manufacturer be indicated on the medicine’s label.

“SB 598 recognizes that because biologic medicines are not the same as chemically-based generic medicines they need their own set of rules,” Bukowski said.

The committee also heard from Geoffrey Eich, executive director of regulatory affairs at Amgen.

California is known as the “birthplace of biotechnology,” where life-saving biologics such as Avastin and Epogen were developed. The state’s biopha
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Brian Cousins Joins Opedix Joint Support Athletic Wear as Vice President of Business Development
2. Nerium New Hire - Vice President of US Operations
3. California Healthcare Institute Appoints Vice President-State Government Affairs
4. Archie Cullen Named President of BioReliance
5. BioHealth Innovation, Inc. President & CEO Richard Bendis to Present at SXSW 2013 & 2013 BIO International Convention
6. BIOCOM Names Rick Fultz Vice President of Business Development
7. AMRI Promotes Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia
8. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
9. Cellular Biomedicine Group President Presents Keynote Address at New York Stem Cell Summit
10. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
11. Society for Brain Mapping and Therapeutics endorse President Obamas support for Human Brain Mapping research; nominating him for prestigious Pioneer in Healthcare Policy Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... August 26, 2014 New research ... wearable technology, and inspiration for the International Year ... year’s brighter, busier SPIE Optics + Photonics ... More than 4,400 international scientists, engineers, researchers, developers, ... exhibition, and industry sessions sponsored by SPIE, ...
(Date:8/26/2014)... team of engineers from Singapore has successfully piloted ... for satellite communications. , With the weight of ... constructing a lightweight, low power-consuming, wireless communication system ... has always been a challenge for system designers. ... Centre of Nanyang Technological University in Singapore launched ...
(Date:8/26/2014)... Aug. 26, 2014 An analysis by Replikins, ... all Dengue virus strains in Pubmed, has revealed extensive ... 1944. This conservation and sharing of specific Replikin gene ... Blocker-Vaccine™ candidate, as it did for the H5N1 influenza ... which have been found to be effective (1,2). ...
(Date:8/26/2014)... , Aug. 26, 2014 Technology Applications ... symbol (NUUU) has two (2) wholly- owned subsidiaries, ... subsidiaries harness scientifically advanced technology to provide advanced ... NUUU,s Renuell Int,l, Inc. is launching its ... care products that is made possible because of ...
Breaking Biology Technology:Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 3Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 4ZigBee in the Sky 2Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2
... the, prior year,s third quarter - Earnings per share of $0.28, ... cash flow of $23 million, (Year-to-date operating cash flow of $62 million) ... ... Biosciences,Corporation (Nasdaq: MATK ) today announced its financial results for the,third ...
... The Hamner Institutes and The University of North Carolina-Chapel ... Research Partnership in Drug Safety Sciences, RESEARCH TRIANGLE ... Sciences and the University of North Carolina at,Chapel Hill ... Safety,Sciences that will be led by Dr. Paul Watkins, ...
... /Xinhua-PRNewswire-FirstCall/ -- Genesis,Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: ... in the People,s Republic,of China, today announced that ... common stock which will begin trading under the ... common stock will no longer trade,under the symbol ...
Cached Biology Technology:Martek Announces Third Quarter 2008 Financial Results 2Martek Announces Third Quarter 2008 Financial Results 3Martek Announces Third Quarter 2008 Financial Results 4Martek Announces Third Quarter 2008 Financial Results 5Martek Announces Third Quarter 2008 Financial Results 6Martek Announces Third Quarter 2008 Financial Results 7Martek Announces Third Quarter 2008 Financial Results 8Martek Announces Third Quarter 2008 Financial Results 9Martek Announces Third Quarter 2008 Financial Results 10New Hamner-UNC Center for Drug Safety Sciences 2New Hamner-UNC Center for Drug Safety Sciences 3Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 2Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 3
(Date:8/27/2014)... A growing number of studies have shown ... the pathogenesis of Parkinson,s disease. Previous studies ... Medical University in China have shown that ... injury, reduced divalent metal transporter 1 expression, ... substantia nigra of rotenone-induced Parkinson,s disease rats. ...
(Date:8/27/2014)... Happy Camp Complex of fires had consumed 24,939 acres ... consumed 35,530 as of eight hours ago. , ... Ranger District of the Klamath National Forest when a ... All but three of those fires are now 100 ... fires and their size at containment: Delta, 150 acres; ...
(Date:8/27/2014)... Carolina State University have found that century-old museum specimens hold ... insect pest that can weaken and kill trees and ... scale insect populations increase on oak and maple trees in ... may also increase with global warming," says Dr. Elsa Youngsteadt, ... a paper on the work. , "More scale insects would ...
Breaking Biology News(10 mins):Happy Camp and July Fire Complexes in California 2Museum specimens, modern cities show how an insect pest will respond to climate change 2
... and microorganisms, Systems Biology is regarded as the next ... allow biologists to spell all the letters in the ... way of deciphering this complex code. Pharma- and biotechnology ... tools for use in drug discovery and development., Systems ...
... cells, high school students and teachers sounds like a witches brew ... Instead, these are the components that ... curriculum being developed by researchers at Washington University in St. Louis ... Lars Angenent, Ph.D., assistant ...
... Commonwealth University Massey Cancer Center research team has received ... National Cancer Institute to improve the activity of a ... in the treatment of leukemia and other blood malignancies. ... associate director for translational research and co-leader of the ...
Cached Biology News:World class in Systems Biology is the aim 2World class in Systems Biology is the aim 3World class in Systems Biology is the aim 4Microbial fuel cells turn on the juice 2Microbial fuel cells turn on the juice 3NCI renewal grant to develop new cancer therapies 2
...
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: